Human Challenge Trials as Topic [pokusy na lidech jako téma]

topical
Terms

model kontrolované lidské infekce jako téma
modely řízené lidské infekce jako téma
pokus na lidech jako téma
testy infekcí na lidských dobrovolnících jako téma

 

Controlled Human Infection Models as Topic
Human Challenge Trial Design

Persistent link   https://www.medvik.cz/link/D000098365
Definition

Works about trials in which participants are intentionally challenged (whether or not they have been vaccinated) with exposure to an infectious disease organism.

Annotation
for general design, methodology, economics, etc. of human challenge trials; a different heading HUMAN CHALLENGE TRIALS is used for reports of a specific adaptive clinical trial
DUI
D000098365 MeSH Browser
CUI
M000766497
History note
2025
Public note
2025

Allowable subheadings

AE
adverse effects
CL
classification
EC
economics
ES
ethics
HI
history
IS
instrumentation
LJ
legislation & jurisprudence
MT
methods
OG
organization & administration
PX
psychology
ST
standards
SN
statistics & numerical data
TD
trends

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E05 Investigative Techniques 209
E05.318 Epidemiologic Methods 1 030
E05.318.372 Epidemiologic Study Characteristics 34
E05.318.372.250 Clinical Studies as Topic 3 382
E05.318.372.250.250 Clinical Trials as Topic 4 826
E05.318.372.250.250.100 Adaptive Clinical Trials as Topic 1
E05.318.372.250.250.200 Clinical Trials, Phase I as Topic 171
E05.318.372.250.250.210 Clinical Trials, Phase II as Topic 487
E05.318.372.250.250.220 Clinical Trials, Phase III as Topic 1 417
E05.318.372.250.250.230 Clinical Trials, Phase IV as Topic 51
E05.318.372.250.250.365 Controlled Clinical Trials as Topic 165
E05.318.372.250.250.524 Human Challenge Trials as Topic
E05.318.372.250.250.682 Single-Case Studies as Topic 2

N Health Care
N05 Health Care Quality, Access, and Evaluation 687
N05.715 Quality of Health Care 2 496
N05.715.360 Health Care Evaluation Mechanisms 202
N05.715.360.330 Epidemiologic Study Characteristics 34
N05.715.360.330.250 Clinical Studies as Topic 3 382
N05.715.360.330.250.250 Clinical Trials as Topic 4 826
N05.715.360.330.250.250.100 Adaptive Clinical Trials as Topic 1
N05.715.360.330.250.250.200 Clinical Trials, Phase I as Topic 171
N05.715.360.330.250.250.210 Clinical Trials, Phase II as Topic 487
N05.715.360.330.250.250.220 Clinical Trials, Phase III as Topic 1 417
N05.715.360.330.250.250.230 Clinical Trials, Phase IV as Topic 51
N05.715.360.330.250.250.365 Controlled Clinical Trials as Topic 165
N05.715.360.330.250.250.524 Human Challenge Trials as Topic
N05.715.360.330.250.250.682 Single-Case Studies as Topic 2
N06 Environment and Public Health 203
N06.850 Public Health 4 047
N06.850.520 Epidemiologic Methods 1 030
N06.850.520.450 Epidemiologic Study Characteristics 34
N06.850.520.450.250 Clinical Studies as Topic 3 382
N06.850.520.450.250.250 Clinical Trials as Topic 4 826
N06.850.520.450.250.250.100 Adaptive Clinical Trials as Topic 1
N06.850.520.450.250.250.200 Clinical Trials, Phase I as Topic 171
N06.850.520.450.250.250.210 Clinical Trials, Phase II as Topic 487
N06.850.520.450.250.250.220 Clinical Trials, Phase III as Topic 1 417
N06.850.520.450.250.250.230 Clinical Trials, Phase IV as Topic 51
N06.850.520.450.250.250.365 Controlled Clinical Trials as Topic 165
N06.850.520.450.250.250.524 Human Challenge Trials as Topic
N06.850.520.450.250.250.682 Single-Case Studies as Topic 2

Add